HCA
Neutral signalScored 2026-10-06 Drivers: Congress, fundamentals. Insiders: neutral. Moteurs : Congrès, fondamentaux. Initiés : neutre.
Research, not advice.
À propos
HCA Healthcare, Inc.
- Nom
- HCA Healthcare, Inc.
- Secteur
- Healthcare
- Industrie
- Medical - Care Facilities
- Bourse
- NYSE
- Capitalisation
- $101.2B
- Employés
- 320,000
- PDG
- Samuel N. Hazen
- Site web
- https://www.hcahealthcare.com
- Marché
- ARDTCYHFSNUYPACSRMYHYTHC
HCA Healthcare, Inc., operating through its subsidiaries, delivers a comprehensive array of healthcare services throughout the United States. The organization manages a network of general and acute care hospitals that provide a full spectrum of medical and surgical care, encompassing inpatient services, intensive care, cardiac treatment, diagnostic procedures, and emergency services. These hospitals additionally offer a broad range of outpatient care, such as ambulatory surgery, laboratory testing, radiology, respiratory therapy, cardiology, and physical therapy. Beyond its hospital infrastructure, HCA Healthcare operates numerous specialized outpatient facilities. These include standalone ambulatory surgery centers, dedicated emergency care facilities, urgent care clinics, walk-in clinics, advanced diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology treatment facilities, physician practices, and various other healthcare sites. Furthermore, the company oversees psychiatric hospitals, which offer diverse therapeutic programs. These services cater to child, adolescent, and adult psychiatric care, alongside adolescent and adult alcohol and drug abuse treatment and counseling. As of December 31, 2021, HCA Healthcare's extensive portfolio included 182 hospitals, specifically 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals. Its network also featured 125 freestanding surgery centers and 21 freestanding endoscopy centers, all distributed across 20 states and England. Founded in 1968 and formerly known as HCA Holdings, Inc., the company's corporate headquarters are situated in Nashville, Tennessee.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
Decouvert par les declarations du Congres
- Insiders
- —
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
—
Avg sell (VWAP, 90d window) —
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
- Last activity
- —
- Last synced
-
2026-10-06 10:56:08
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
No Form 4 filings for this company in this window.
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
| Date | Member | Side | Amount range | Filing |
|---|---|---|---|---|
| 2026-09-04 | Ro Khanna | Buy | $1,001 - $15,000 | Filing |
| 2026-06-30 | William R. Keating | Buy | $15,001 - $50,000 | Filing |
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2026-06-17 | Jared Moskowitz | Purchase | $1,001 - $15,000 |
| 2026-06-17 | Jared Moskowitz | Purchase | $1,001 - $15,000 |
| 2025-10-27 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2025-10-27 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2025-10-27 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2025-10-27 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2025-09-11 | Lisa C. McClain | Sale (Full) | $1,001 - $15,000 |
| 2025-08-19 | Lisa C. McClain | Purchase | $1,001 - $15,000 |
| 2025-05-15 | Jared Moskowitz | Purchase | $1,001 - $15,000 |
| 2025-05-15 | Jared Moskowitz | Purchase | $1,001 - $15,000 |
| 2025-04-07 | Julie Johnson | Sale (Full) | $1,001 - $15,000 |
| 2025-02-25 | Robert P. Bresnahan | Sale (Full) | $1,001 - $15,000 |
| 2024-12-27 | Val Hoyle | Sale (Full) | $1,001 - $15,000 |
| 2024-10-29 | Val Hoyle | Purchase | $1,001 - $15,000 |
| 2024-10-15 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2024-06-12 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2024-03-01 | Josh S. Gottheimer | Sale (Full) | $1,001 - $15,000 |
| 2024-02-13 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2024-01-10 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-11-28 | Josh S. Gottheimer | Sale | $1,001 - $15,000 |
| 2023-11-13 | Josh S. Gottheimer | Sale | $1,001 - $15,000 |
| 2023-11-03 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-10-31 | Ro Khanna | Sale | $15,001 - $50,000 |
| 2023-10-02 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-09-13 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-09-13 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-07-18 | Josh S. Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2023-05-25 | Zoe Lofgren | Sale (Full) | $1,001 - $15,000 |
| 2023-05-10 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-05-10 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-04-12 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-04-12 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-01-27 | Josh S. Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2023-01-11 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-12-06 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-11-30 | Susie Lee | Sale (Full) | $1,001 - $15,000 |
| 2022-10-21 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-10-21 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-10-20 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-10-20 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-09-28 | Josh S. Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2022-09-26 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-09-15 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-09-08 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-08-23 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-08-03 | Kathy E. Manning | Sale (Full) | $1,001 - $15,000 |
| 2022-08-01 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-07-20 | Kathy E. Manning | Purchase | $1,001 - $15,000 |
| 2022-07-19 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-06-29 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-06-29 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-06-28 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-06-28 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-06-27 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-06-23 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-06-23 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-06-21 | Josh S. Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2022-06-21 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-06-21 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-06-17 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-05-23 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-05-05 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-04-11 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-02-17 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-01-21 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2021-09-30 | Zoe Lofgren | Purchase | $1,001 - $15,000 |
| 2021-08-02 | Zoe Lofgren | Sale (Full) | $1,001 - $15,000 |
| 2021-06-15 | Susie Lee | Purchase | $1,001 - $15,000 |
| 2021-03-16 | Josh S. Gottheimer | Purchase | $1,001 - $15,000 |
| 2021-02-09 | Susie Lee | Sale (Partial) | $1,001 - $15,000 |
| 2021-01-04 | Josh S. Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2020-11-16 | Josh S. Gottheimer | Purchase | $1,001 - $15,000 |
| 2020-06-15 | Zoe Lofgren | Purchase | $1,001 - $15,000 |
| 2020-04-07 | Susie Lee | Sale (Partial) | $1,001 - $15,000 |
| 2020-04-03 | Susie Lee | Sale (Partial) | $1,001 - $15,000 |
| 2019-05-08 | Bill Flores | Purchase | $1,001 - $15,000 |
| 2019-03-25 | Bill Flores | Purchase | $1,001 - $15,000 |
| 2019-03-14 | Susie Lee | Purchase | $1,001 - $15,000 |
Signal
Neutral signalScored 2026-10-06 Drivers: Congress, fundamentals. Insiders: neutral. Moteurs : Congrès, fondamentaux. Initiés : neutre.
HCA presents a deeply unfavorable risk/reward profile: a weak liquidity score (40) reflects a current ratio below 1.0, negative equity, and dangerously high leverage (debt-to-assets at 0.83), while the near-absent…
The first sentence of the analysis written for HCA on 2026-10-06 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Unavailable or mixed. No open-market purchase or sale value stored
- Congress Supports a bullish reading. 2 purchase disclosures year to date
- Narrative Pulls against a bullish reading. Stored narrative reading is in the bearish band
- Timing Unavailable or mixed. No stored price series
- Financial indicators Unavailable or mixed. Current ratio 0.83 · operating margin 16% — readings disagree
Market snapshot
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 41.5% | 40.6% | 39.4% | 38.5% | 38.3% | |
| Ebit Margin | 16.0% | 15.0% | 14.8% | 17.1% | 19.4% | |
| Ebitda Margin | 20.6% | 19.7% | 19.6% | 22.1% | 24.3% | |
| Operating Profit Margin | 15.8% | 14.9% | 14.8% | 15.0% | 16.5% | |
| Pretax Profit Margin | 13.0% | 12.1% | 11.9% | 14.2% | 16.7% | |
| Continuous Operations Profit Margin | 10.3% | 9.4% | 9.4% | 11.3% | 13.1% | |
| Net Profit Margin | 9.0% | 8.2% | 8.1% | 9.4% | 11.8% | |
| Bottom Line Profit Margin | 9.0% | 8.2% | 8.1% | 9.4% | 11.8% | |
| Current Ratio | 0.829 | 1.082 | 1.180 | 1.378 | 1.413 | |
| Quick Ratio | 0.728 | 0.967 | 1.020 | 1.169 | 1.206 | |
| Solvency Ratio | 0.162 | 0.154 | 0.151 | 0.164 | 0.199 | |
| Cash Ratio | 0.064 | 0.127 | 0.074 | 0.092 | 0.151 | |
| Price To Earnings Ratio | 16.312 | 13.478 | 14.069 | 12.344 | 11.944 | |
| Price To Earnings Growth Ratio | 0.572 | 0.856 | -13.675 | -1.283 | 0.127 | |
| Forward Price To Earnings Growth Ratio | 0.572 | 0.856 | -13.675 | -1.283 | 0.127 | |
| Price To Earnings Diluted Ratio | 16.450 | 13.643 | 14.276 | 12.531 | 12.142 | |
| Price To Earnings Diluted Growth Ratio | 0.567 | 0.851 | -14.389 | -1.319 | 0.130 | |
| Price To Book Ratio | -17.871 | -31.060 | -41.564 | -25.180 | -89.031 | |
| Price To Sales Ratio | 1.425 | 1.099 | 1.135 | 1.157 | 1.414 | |
| Price To Free Cash Flow Ratio | 14.003 | 13.765 | 15.732 | 16.882 | 15.434 | |
| Price To Operating Cash Flow Ratio | 8.524 | 7.383 | 7.818 | 8.176 | 9.272 | |
| Debt To Assets Ratio | 0.827 | 0.760 | 0.745 | 0.767 | 0.724 | |
| Debt To Equity Ratio | -8.329 | -18.102 | -23.596 | -14.528 | -39.363 | |
| Debt To Capital Ratio | 1.136 | 1.058 | 1.044 | 1.074 | 1.026 | |
| Long Term Debt To Capital Ratio | 1.169 | 1.070 | 1.050 | 1.081 | 1.028 | |
| Financial Leverage Ratio | -10.075 | -23.815 | -31.686 | -18.951 | -54.386 | |
| Working Capital Turnover Ratio | -97.297 | 40.241 | 21.609 | 15.643 | 15.483 | |
| Operating Cash Flow Ratio | 0.773 | 0.693 | 0.745 | 0.861 | 0.935 | |
| Operating Cash Flow Sales Ratio | 0.167 | 0.149 | 0.145 | 0.141 | 0.152 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.609 | 0.536 | 0.497 | 0.484 | 0.601 | |
| Debt Service Coverage Ratio | 1.508 | 1.780 | 2.546 | 5.474 | 6.874 | |
| Interest Coverage Ratio | 5.323 | 5.117 | 4.967 | 5.206 | 6.330 | |
| Short Term Operating Cash Flow Coverage Ratio | 1.874 | 2.238 | 3.891 | 23.032 | 37.802 | |
| Operating Cash Flow Coverage Ratio | 0.252 | 0.232 | 0.225 | 0.212 | 0.244 | |
| Capital Expenditure Coverage Ratio | 2.556 | 2.157 | 1.988 | 1.939 | 2.505 | |
| Dividend Paid And Capex Coverage Ratio | 2.247 | 1.889 | 1.745 | 1.688 | 2.133 | |
| Dividend Payout Ratio | 0.100 | 0.120 | 0.126 | 0.116 | 0.090 | |
| Enterprise Value Multiple | 10.054 | 8.702 | 9.013 | 8.199 | 8.303 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 41.5% | ▲0.9% | ▲1.8% |
| Ebit Margin | 16.0% | ▲1.0% | ▼-0.5% |
| Ebitda Margin | 20.6% | ▲1.0% | ▼-0.6% |
| Operating Profit Margin | 15.8% | ▲0.9% | ▲0.4% |
| Pretax Profit Margin | 13.0% | ▲0.9% | ▼-0.6% |
| Continuous Operations Profit Margin | 10.3% | ▲0.9% | ▼-0.4% |
| Net Profit Margin | 9.0% | ▲0.8% | ▼-0.3% |
| Bottom Line Profit Margin | 9.0% | ▲0.8% | ▼-0.3% |
| Current Ratio | 0.829 | ▼-0.252 | ▼-0.347 |
| Quick Ratio | 0.728 | ▼-0.239 | ▼-0.290 |
| Solvency Ratio | 0.162 | ▲0.009 | ▼-0.004 |
| Cash Ratio | 0.064 | ▼-0.064 | ▼-0.038 |
| Price To Earnings Ratio | 16.312 | ▲2.835 | ▲2.683 |
| Price To Earnings Growth Ratio | 0.572 | ▼-0.284 | ▲3.253 |
| Forward Price To Earnings Growth Ratio | 0.572 | ▼-0.284 | ▲3.253 |
| Price To Earnings Diluted Ratio | 16.450 | ▲2.807 | ▲2.642 |
| Price To Earnings Diluted Growth Ratio | 0.567 | ▼-0.284 | ▲3.399 |
| Price To Book Ratio | -17.871 | ▲13.189 | ▲23.070 |
| Price To Sales Ratio | 1.425 | ▲0.325 | ▲0.179 |
| Price To Free Cash Flow Ratio | 14.003 | ▲0.238 | ▼-1.160 |
| Price To Operating Cash Flow Ratio | 8.524 | ▲1.141 | ▲0.290 |
| Debt To Assets Ratio | 0.827 | ▲0.067 | ▲0.062 |
| Debt To Equity Ratio | -8.329 | ▲9.773 | ▲12.455 |
| Debt To Capital Ratio | 1.136 | ▲0.078 | ▲0.069 |
| Long Term Debt To Capital Ratio | 1.169 | ▲0.100 | ▲0.090 |
| Financial Leverage Ratio | -10.075 | ▲13.740 | ▲17.708 |
| Working Capital Turnover Ratio | -97.297 | ▼-137.538 | ▼-96.433 |
| Operating Cash Flow Ratio | 0.773 | ▲0.080 | ▼-0.028 |
| Operating Cash Flow Sales Ratio | 0.167 | ▲0.018 | ▲0.016 |
| Free Cash Flow Operating Cash Flow Ratio | 0.609 | ▲0.072 | ▲0.063 |
| Debt Service Coverage Ratio | 1.508 | ▼-0.272 | ▼-2.129 |
| Interest Coverage Ratio | 5.322 | ▲0.205 | ▼-0.066 |
| Short Term Operating Cash Flow Coverage Ratio | 1.874 | ▼-0.364 | ▼-11.893 |
| Operating Cash Flow Coverage Ratio | 0.252 | ▲0.019 | ▲0.019 |
| Capital Expenditure Coverage Ratio | 2.556 | ▲0.399 | ▲0.327 |
| Dividend Paid And Capex Coverage Ratio | 2.247 | ▲0.358 | ▲0.307 |
| Dividend Payout Ratio | 0.100 | ▼-0.020 | ▼-0.010 |
| Enterprise Value Multiple | 10.054 | ▲1.352 | ▲1.199 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $107.71B | $77.62B | $73.73B | $69.67B | $83.07B | |
| Enterprise value | $156.87B | $120.92B | $114.66B | $108.96B | $118.34B | |
| EV / Sales | 2.08x | 1.71x | 1.76x | 1.81x | 2.01x | |
| EV / Op. cash flow | 12.41x | 11.50x | 12.16x | 12.79x | 13.21x | |
| EV / Free cash flow | 20.39x | 21.44x | 24.46x | 26.40x | 21.99x | |
| EV / EBITDA | 10.05x | 8.70x | 9.01x | 8.20x | 8.30x | |
| Net debt / EBITDA | 3.15x | 3.12x | 3.22x | 2.96x | 2.48x | |
| Current ratio | 0.83x | 1.08x | 1.18x | 1.38x | 1.41x | |
| Income quality | 1.86x | 1.58x | 1.80x | 1.25x | 1.16x | |
| Graham net-net | -$232 | -$186 | -$168 | -$151 | -$126 | |
| Tax burden | 69.0% | 67.6% | 68.0% | 65.8% | 70.7% | |
| Interest burden | 81.4% | 80.5% | 79.9% | 83.1% | 86.3% | |
| Working capital | -$2.79B | $1.24B | $2.27B | $3.74B | $3.96B | |
| Invested capital | $38.64B | $42.88B | $42.14B | $41.03B | $39.68B | |
| Return on assets | 11.2% | 9.7% | 9.3% | 10.8% | 13.7% | |
| Operating ROA | 19.9% | 18.2% | 17.7% | 17.5% | 19.7% | |
| Return on tangible assets | 13.5% | 11.7% | 11.3% | 13.2% | 16.9% | |
| Return on equity | -112.6% | -230.5% | -295.5% | -203.9% | -745.6% | |
| Return on invested capital | 18.5% | 16.7% | 16.4% | 16.7% | 18.2% | |
| Return on capital employed | 27.0% | 23.8% | 22.1% | 21.3% | 23.5% | |
| Earnings yield | 6.3% | 7.4% | 7.1% | 8.1% | 8.4% | |
| Free cash flow yield | 7.1% | 7.3% | 6.4% | 5.9% | 6.5% | |
| Capex / Op. cash flow | 39.1% | 46.4% | 50.3% | 51.6% | 39.9% | |
| Capex / Depreciation | 140.3% | 147.2% | 154.2% | 148.0% | 125.4% | |
| Capex / Sales | 6.5% | 6.9% | 7.3% | 7.3% | 6.1% | |
| SG&A / Sales | 10.6% | 44.1% | 45.4% | 46.0% | 45.6% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 0.0% | 0.5% | 0.0% | 0.6% | 0.7% | |
| Intangibles / Total assets | 17.0% | 17.0% | 17.7% | 18.4% | 18.8% | |
| Days sales outstanding | 52d | 56d | 56d | 54d | 50d | |
| Days payables outstanding | 38d | 37d | 39d | 42d | 41d | |
| Operating cycle | 66d | 71d | 75d | 74d | 70d | |
| Cash conversion cycle | 28d | 33d | 35d | 32d | 29d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Recent news
- 2026-10-06 Nutex Health (NASDAQ:NUTX) versus HCA Healthcare (NYSE:HCA) Head-To-Head Survey HCA Healthcare (NYSE: HCA - Get Free Report) and Nutex Health (NASDAQ: NUTX - Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, dividends, valuation, profitability, institutional ownership, earnings and analyst recommendations. Analyst Ratings This is a breakdown of current
- 2026-10-05 Park National Corp OH Purchases 6,276 Shares of HCA Healthcare, Inc. $HCA Park National Corp OH lifted its holdings in shares of HCA Healthcare, Inc. (NYSE: HCA) by 54.2% during the undefined quarter, according to its most recent disclosure with the SEC. The institutional investor owned 17,851 shares of the company''s stock after purchasing an additional 6,276 shares during the quarter. Park National Corp OH''s
- 2026-10-05 65,181 HCA Healthcare, Inc. $HCA Shares Sold by Argent Capital Management LLC Argent Capital Management LLC trimmed its holdings in HCA Healthcare, Inc. (NYSE: HCA) by 36.8% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 112,176 shares of the company''s stock after selling 65,181 shares during the quarter. HCA Healthcare accounts for about 0.4%
- 2026-10-05 Reviewing HCA Healthcare (NYSE:HCA) & Omada Health (NASDAQ:OMDA) HCA Healthcare (NYSE: HCA - Get Free Report) and Omada Health (NASDAQ: OMDA - Get Free Report) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership. Earnings and Valuation This table compares HCA Healthcare
- 2026-10-01 INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA NEW YORK, Oct. 1, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
- 2026-09-30 HCA Healthcare, Inc. 3rd Quarter 2026 Earnings Conference Call NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast: What: HCA Healthcare, Inc. 3Q 2026 Earnings Call When: Tuesday, October 27, 2026, at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, [email protected] If you are unable to listen during the live webcast, the call will.
- 2026-09-29 INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. – HCA NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
- 2026-09-29 HCA Healthcare Presents 2026 Awards of Distinction NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation''s leading healthcare providers, today presented its annual HCA Healthcare Awards of Distinction at a ceremony in Nashville, Tennessee. The HCA Healthcare Awards of Distinction, which include the Frist Humanitarian Award and the Excellence in Nursing Award, are the highest honors HCA Healthcare bestows on colleagues, nurses, physicians and volunteers, recognizing individuals who exemplify the organization''s cul.
- 2026-09-28 Can Shorter Hospital Stays Help HCA Handle More Patient Demand? HCA''s rising admissions and shorter hospital stays could help it meet growing patient demand while using existing capacity more efficiently.
- 2026-09-24 INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA).